Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Insight Molecular DiagnosticsIMDX | Open-market buy | 04/23–04/27 | 04/27 | 570,184 sh6 trades | $3.56avg. | $2,031,939.62 | No record | |
Insight Molecular DiagnosticsIMDX | Open-market buy | 04/16–04/20 | 04/20 | 182,861 sh6 trades | $3.57avg. | $653,180.83 | No record | |
Insight Molecular DiagnosticsIMDX | Open-market buy | 02/10 | 02/12 | 521,739 sh2 trades | $5.75avg. | $2,999,999.25 | No record |